ZA986047B - 6-pyrrolidin-2-ylpyrindines their preparation and their therapeutic application - Google Patents

6-pyrrolidin-2-ylpyrindines their preparation and their therapeutic application

Info

Publication number
ZA986047B
ZA986047B ZA986047A ZA986047A ZA986047B ZA 986047 B ZA986047 B ZA 986047B ZA 986047 A ZA986047 A ZA 986047A ZA 986047 A ZA986047 A ZA 986047A ZA 986047 B ZA986047 B ZA 986047B
Authority
ZA
South Africa
Prior art keywords
ylpyrindines
pyrrolidin
preparation
therapeutic application
therapeutic
Prior art date
Application number
ZA986047A
Other languages
English (en)
Inventor
Alistair Lochead
Samir Jegham
Frederic Galli
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of ZA986047B publication Critical patent/ZA986047B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Psychology (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA986047A 1997-07-09 1998-07-08 6-pyrrolidin-2-ylpyrindines their preparation and their therapeutic application ZA986047B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9708706A FR2765874B1 (fr) 1997-07-09 1997-07-09 Derives de 6-pyrrolidin-2-ylpyrindines, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
ZA986047B true ZA986047B (en) 1999-02-01

Family

ID=9509040

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA986047A ZA986047B (en) 1997-07-09 1998-07-08 6-pyrrolidin-2-ylpyrindines their preparation and their therapeutic application

Country Status (21)

Country Link
US (1) US6184229B1 (ko)
EP (1) EP1000056A1 (ko)
JP (1) JP2002508004A (ko)
KR (1) KR20010021617A (ko)
CN (1) CN1262680A (ko)
AR (1) AR013192A1 (ko)
AU (1) AU8544498A (ko)
BG (1) BG104037A (ko)
BR (1) BR9811672A (ko)
CA (1) CA2295666A1 (ko)
CO (1) CO4890850A1 (ko)
EE (1) EE200000018A (ko)
FR (1) FR2765874B1 (ko)
HU (1) HUP0003856A2 (ko)
IL (1) IL133536A0 (ko)
NO (1) NO20000066L (ko)
PL (1) PL338123A1 (ko)
SK (1) SK212000A3 (ko)
TR (1) TR200000057T2 (ko)
WO (1) WO1999002517A1 (ko)
ZA (1) ZA986047B (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005126340A (ja) * 2003-10-22 2005-05-19 Kureha Chem Ind Co Ltd 置換ピリドン類の製造法、その原料化合物及びその製造方法
JP5254616B2 (ja) 2004-09-13 2013-08-07 クロノ セラピューティクス、インコーポレイテッド 生物学的同調性（ｂｉｏｓｙｎｃｈｒｏｎｏｕｓ）経皮的薬物送達
WO2008122049A2 (en) 2007-04-02 2008-10-09 Parkinson's Institute Methods and compositions for reduction of side effects of therapeutic treatments
EP3250258A4 (en) 2015-01-28 2018-09-05 Chrono Therapeutics, Inc. Drug delivery methods and systems
JP2020503950A (ja) 2017-01-06 2020-02-06 クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． 経皮薬剤送達の装置及び方法
US11596779B2 (en) 2018-05-29 2023-03-07 Morningside Venture Investments Limited Drug delivery methods and systems

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5227391A (en) * 1992-04-10 1993-07-13 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases
US5232933A (en) * 1992-05-21 1993-08-03 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases

Also Published As

Publication number Publication date
JP2002508004A (ja) 2002-03-12
AU8544498A (en) 1999-02-08
BR9811672A (pt) 2000-09-19
EE200000018A (et) 2000-08-15
HUP0003856A2 (hu) 2001-10-28
NO20000066D0 (no) 2000-01-06
WO1999002517A1 (fr) 1999-01-21
SK212000A3 (en) 2000-06-12
CN1262680A (zh) 2000-08-09
KR20010021617A (ko) 2001-03-15
BG104037A (en) 2001-04-30
FR2765874B1 (fr) 1999-08-13
TR200000057T2 (tr) 2000-08-21
CO4890850A1 (es) 2000-02-28
AR013192A1 (es) 2000-12-13
PL338123A1 (en) 2000-09-25
FR2765874A1 (fr) 1999-01-15
NO20000066L (no) 2000-03-09
US6184229B1 (en) 2001-02-06
IL133536A0 (en) 2001-04-30
EP1000056A1 (fr) 2000-05-17
CA2295666A1 (en) 1999-01-21

Similar Documents

Publication Publication Date Title
IL120124A0 (en) Heteroaryl-oxazolidinones their preparation and use
ZA982478B (en) Compounds their use and preparation
IL118442A0 (en) Triazolymethyl-cyclopentanols their preparation and use
IL118441A0 (en) Triazolymethyl-oxiranes their preparation and use
ZA989556B (en) Benzoxazine derivatives their preparation and their therapeutic application
ZA9810558B (en) Imidazole derivatives their preparation and their therapeutic application
GB9712761D0 (en) Quinolines and their therapeutic use
AU2529799A (en) Benzofuran-4-carboxamides and their therapeutic use
ZA986047B (en) 6-pyrrolidin-2-ylpyrindines their preparation and their therapeutic application
PL328334A1 (en) Preparation and application thereof
IL118444A0 (en) Mercapto-triazolyl-silanes their preparation and use
IL122686A0 (en) Benzylhydroxylamines their preparation and use
GB9723999D0 (en) Therapeutic use
GB9726701D0 (en) Therapeutic use
GB9704350D0 (en) Compounds and their therapeutic use
GB9525891D0 (en) Therapeutic agents and their preparation
GB9725044D0 (en) Microparticles and their therapeutic use
ZA9810117B (en) Pyridylether derivatives their preparation and use
AU1931399A (en) Human dendriac and brainiac-3
GB9714298D0 (en) Quinolines and their therapeutic use
GB9714297D0 (en) Benzofurans and their therapeutic use
GB9725637D0 (en) Benzofurans and their therapeutic use
GB9609521D0 (en) Substances and their therapeutic use
GB9621314D0 (en) Substances and their therapeutic use
GB9715323D0 (en) Piperidinecarboxamides and their use